Display options
Cite
Ediriweera GR, Simpson JD, Fuchs AV, et al. Targeted and modular architectural polymers employing bioorthogonal chemistry for quantitative therapeutic delivery. Chem Sci. 2020;11(12):3268-3280doi: 10.1039/d0sc00078g.
Ediriweera, G. R., Simpson, J. D., Fuchs, A. V., Venkatachalam, T. K., Van De Walle, M., Howard, C. B., Mahler, S. M., Blinco, J. P., Fletcher, N. L., Houston, Z. H., Bell, C. A., & Thurecht, K. J. (2020). Targeted and modular architectural polymers employing bioorthogonal chemistry for quantitative therapeutic delivery. Chemical science, 11(12), 3268-3280. https://doi.org/10.1039/d0sc00078g
Ediriweera, Gayathri R, et al. "Targeted and modular architectural polymers employing bioorthogonal chemistry for quantitative therapeutic delivery." Chemical science vol. 11,12 (2020): 3268-3280. doi: https://doi.org/10.1039/d0sc00078g
Ediriweera GR, Simpson JD, Fuchs AV, Venkatachalam TK, Van De Walle M, Howard CB, Mahler SM, Blinco JP, Fletcher NL, Houston ZH, Bell CA, Thurecht KJ. Targeted and modular architectural polymers employing bioorthogonal chemistry for quantitative therapeutic delivery. Chem Sci. 2020 Mar 06;11(12):3268-3280. doi: 10.1039/d0sc00078g. PMID: 34122834; PMCID: PMC8157365.
Copy Download .nbib Format: NLM
Share it on

Chem Sci. 2020 Mar 06;11(12):3268-3280. doi: 10.1039/d0sc00078g.

Targeted and modular architectural polymers employing bioorthogonal chemistry for quantitative therapeutic delivery.

Chemical science

Gayathri R Ediriweera, Joshua D Simpson, Adrian V Fuchs, Taracad K Venkatachalam, Matthias Van De Walle, Christopher B Howard, Stephen M Mahler, James P Blinco, Nicholas L Fletcher, Zachary H Houston, Craig A Bell, Kristofer J Thurecht

Affiliations

  1. Centre for Advanced Imaging, The University of Queensland Brisbane QLD 4072 Australia [email protected].
  2. Australian Institute for Bioengineering & Nanotechnology (AIBN), The University of Queensland Brisbane QLD 4072 Australia.
  3. ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, ARC Training Centre for Innovation in Biomedical Imaging Technology, The University of Queensland Brisbane QLD 4072 Australia.
  4. School of Chemistry, Physics and Mechanical Engineering, Queensland University of Technology 2 George St Brisbane QLD 4000 Australia.
  5. ARC Training Centre for Biopharmaceutical Innovation, The University of Queensland Brisbane QLD 4072 Australia.

PMID: 34122834 PMCID: PMC8157365 DOI: 10.1039/d0sc00078g

Abstract

There remain several key challenges to existing therapeutic systems for cancer therapy, such as quantitatively determining the true, tissue-specific drug release profile

This journal is © The Royal Society of Chemistry.

Conflict of interest statement

There are no conflicts to declare.

References

  1. Bioorg Med Chem Lett. 2006 Jun 15;16(12):3147-9 - PubMed
  2. Angew Chem Int Ed Engl. 2013 Dec 23;52(52):14112-6 - PubMed
  3. EJNMMI Res. 2017 Dec 02;7(1):95 - PubMed
  4. Angew Chem Int Ed Engl. 2018 Aug 13;57(33):10494-10499 - PubMed
  5. Nat Nanotechnol. 2018 Sep;13(9):777-785 - PubMed
  6. Oncotarget. 2016 Nov 8;7(45):73618-73637 - PubMed
  7. J Am Chem Soc. 2008 Mar 26;130(12):3760-1 - PubMed
  8. Angew Chem Int Ed Engl. 2009;48(38):6974-98 - PubMed
  9. Bioconjug Chem. 2011 Oct 19;22(10):1879-903 - PubMed
  10. Theranostics. 2013 Oct 07;3(10):787-801 - PubMed
  11. Mol Pharm. 2018 Apr 2;15(4):1729-1734 - PubMed
  12. Bioconjug Chem. 2016 Jul 20;27(7):1697-706 - PubMed
  13. Mol Pharm. 2015 Oct 5;12(10):3575-87 - PubMed
  14. Bioconjug Chem. 2016 Dec 21;27(12):2791-2807 - PubMed
  15. J Drug Deliv. 2013;2013:374252 - PubMed
  16. J Immunol Methods. 1993 Jan 4;157(1-2):233-40 - PubMed
  17. Oncol Rep. 2014 Jun;31(6):2735-42 - PubMed
  18. ACS Cent Sci. 2016 Jul 27;2(7):476-82 - PubMed
  19. Theranostics. 2016 Apr 12;6(6):887-95 - PubMed
  20. Am J Nucl Med Mol Imaging. 2014 Mar 20;4(2):96-113 - PubMed
  21. Bioconjug Chem. 2015 Feb 18;26(2):352-60 - PubMed
  22. Nat Rev Cancer. 2017 Jan;17(1):20-37 - PubMed
  23. Chem Biol. 2014 Sep 18;21(9):1075-101 - PubMed
  24. Nanomedicine (Lond). 2008 Apr;3(2):137-40 - PubMed
  25. Curr Cancer Drug Targets. 2016;16(7):639-49 - PubMed
  26. Mol Pharm. 2017 Oct 2;14(10):3539-3549 - PubMed
  27. J Nucl Med. 2009 May;50 Suppl 1:11S-20S - PubMed
  28. J Am Chem Soc. 2018 Mar 14;140(10):3603-3612 - PubMed
  29. Adv Healthc Mater. 2016 Aug;5(16):2055-68 - PubMed
  30. Cancer Res. 1985 Feb;45(2):833-40 - PubMed
  31. Nat Commun. 2018 May 4;9(1):1484 - PubMed
  32. J Nucl Med. 2013 Nov;54(11):1989-95 - PubMed
  33. Bioconjug Chem. 2018 Feb 21;29(2):250-254 - PubMed
  34. Chem Commun (Camb). 2014 Aug 28;50(67):9557-60 - PubMed
  35. Chem Sci. 2015 Feb 1;6(2):1212-1218 - PubMed
  36. MAbs. 2015;7(1):53-65 - PubMed
  37. Bioconjug Chem. 2018 Feb 21;29(2):324-334 - PubMed
  38. Nat Chem Biol. 2016 Mar;12(3):129-37 - PubMed
  39. Angew Chem Int Ed Engl. 2016 Nov 2;55(45):14046-14050 - PubMed
  40. Bioconjug Chem. 2008 Dec;19(12):2409-16 - PubMed
  41. Biomaterials. 2017 Oct;141:330-339 - PubMed
  42. Mol Pharm. 2017 Jul 3;14(7):2307-2313 - PubMed
  43. Chem Commun (Camb). 2013 May 10;49(37):3836-8 - PubMed
  44. J Am Chem Soc. 2011 Jun 29;133(25):9646-9 - PubMed
  45. Biochim Biophys Acta. 2014 Jan;1845(1):84-9 - PubMed
  46. Angew Chem Int Ed Engl. 2010 Aug 23;49(36):6288-308 - PubMed
  47. Chem Soc Rev. 2017 Aug 14;46(16):4895-4950 - PubMed
  48. Expert Opin Biol Ther. 2015;15(9):1251-5 - PubMed
  49. Nanotheranostics. 2018 Aug 24;2(4):360-370 - PubMed
  50. Pharmacol Rev. 2016 Jan;68(1):3-19 - PubMed

Publication Types